Presentacion microbiologia
TRADUCCIÓN AL ESPAÑOL
Ministerio de Salud Subsecretaria de Programas de Prevención y Promoción
Programa de Vigilancia de la Salud y Control de Enfermedades
Administración Nacional de Laboratorios e Institutos de Salud
GRUPO REVISOR Raquel Terragno Angel José Cingara Elsa Graciela Bauminster Liliana Beatriz Latapie AnaMaría Ambrosio Ana María de Risso Osvaldo Rico Cordeiro Química. Médico Veterinario. Bioquímica. Química. Bioquímica. Bioquímica Epidemiólogo. INEI “Dr. Carlos G. Malbrán” INP “Dr. Mario Fatala Chaben” INEI “Dr. Carlos G. Malbrán” INEI “Dr. Carlos G. Malbrán” INEVH “Dr. Julio Maiztegui” INP “Dr. Mario Fatala Chaben” Vigilancia de la Salud. VIGI+A
EDITORES
Jonathan Y. Richmond, Ph. D.Director, Office of Health and Safety Public Health Service Centers for Disease Control and Prevention 1600 Clifton Road N.E. Atlanta, Georgia 30333
Robert W. McKinney, PH.D. Director, Division of Safety Public Health Service National Institutes of Health Building 31, Room 1C02 Bethesda Maryland 20892
I
EDITORES INVITADOS
Centers for Disease Control Prevention
Robert B. Craven, M.D.Chief, Epidemiology Section Arbovirus Disease Branch National Center for Infectious Diseases Chief Biology and Diagnostics Branch Division of Parasitic Diseases National Center for Infectious Diseases Chief HIV and Retroviroly Branch Division of AIDS, STD, and Laboratory Research National Center for Infectious Diseases Senior Laboratory Advisor Division of Bacteriology and Mycotic DiseasesNational Center Infectious Diseases Chief Labboratory Safety Branch Office of Health and Safety Director Division of Viral and Rickettsial Diseases National Center for Infectious Diseases Chief Special Pathogens Branch National Center for Infectious Diseases Chief External Activities Program Office of Health and Safety
Mark L. Eberhard, Ph.D.
Thomas Folks, Ph.D.
Bradford Kay, Dr. P.H.Richard C. Knudsen, Ph. D.
Brian W.J. Mahy, Sc.D., Ph.D.
C.J. Peters, M.D.
Margaret A. Tipple, M.D.
II
John Bennett, M.D.
Chief, Micology Section National Institute for Allergies and Infectious Diseases Microbiologist Rocky Mountain Laboratory Chief, Occupational Health and Safety Branch Division of Safety
David Hackstadt, PH.D.
Deborah E. Wilson, Dr. P.H.
EDITORESINVITADOS INDIVIDUALES Jonathan Crane, A.I.A. Architect Atlanta, GA Director, Tulane Regional Primate Research Center Tulane University Medical Center Covington, Louisiana Consultant Cary, NC Director, Biological Safety and Infection Control Duke University Medical Center Durham, North Carolina Senior Research Scientist Disease Assessment Division USAMRIID Frederick, Maryland Section HeadMolecular Sciences Department Glaxo Welcome, Inc. Research Triangle Park, NC
Peter J. Gerone, Sc.D.
Thomas Hamm, D.V.M. Ph.D. Debra L. Hunt, Dr. P.H.
Peter Jahrling, Ph.D.
Thomas Kost, Ph.D.
EDITOR TECNICO Marie J. Murray Writer-Editor Atlanta, GA
III
ÍNDICE
SECCIÓN I Introducción..............................................................................................1SECCIÓN II Principios de Bioseguridad.......................................................................5 SECCIÓN III Criterios de Nivel de Bioseguridad de los Laboratorios.......................12 Tabla 1. Resumen de los Niveles de Bioseguridad Recomendados para Agentes Infecciosos.......................37 SECCIÓN IV Criterios de Nivel de Bioseguridad de los AnimalesVertebrados...........38 Tabla 1. Resumen de los Niveles de Bioseguridad Recomendados para las Actividades en las cuales se utilizan Animales Vertebrados Infectados Natural o Experimentalmente........................55 SECCIÓN V Evaluación de Riesgo..............................................................................56 SECCIÓN VI Niveles de Bioseguridad recomendados para Agentes Infecciosos y Animales...
Regístrate para leer el documento completo.